Press Releases

HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug

The Company will seek Orphan Drug Designation to significantly reduce time to market Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce the completion of the …

HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug Read More »

havn life production agreement announcement LOBE

HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings

Natural health products will be manufactured and packaged at the Company’s new facility Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce a production and supply …

HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings Read More »

HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches

HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches

HAVN Life works towards substantiating a patent application and preclinical work Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that it has entered into a …

HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches Read More »

Supply-Agreement-Havn-Lifre-ATMA.png

Havn Life Signs Exclusive Supply Agreement With ATMA Journey Centers

Havn Life to supply naturally-derived psilocybin to ATMA Journey Centers in Alberta and Nicoya Peninsula, Costa Rica Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce …

Havn Life Signs Exclusive Supply Agreement With ATMA Journey Centers Read More »

Havn Life Develops New Method for Rapid Psilocybin Testing

Havn Life has completed its analytical work under its Health Canada Section 56 exemption   Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that it …

Havn Life Develops New Method for Rapid Psilocybin Testing Read More »

Havn Labs Jamaica Facility Now Fully Operational

Havn Labs Jamaica Facility Now Fully Operational

The Company has started production of its first grow with local partner Hypha Wellness. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”),  a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that it now …

Havn Labs Jamaica Facility Now Fully Operational Read More »

Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division

The Facility acquisition positions Havn Life to quickly expand its product portfolio and reach additional NHP categories. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce, further to …

Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division Read More »

Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness

Havn Life believes operations can advance its business plan and potentially accelerate production of naturally-derived psilocybin for global medical research. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, has …

Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness Read More »

Havn Life CEO to Present at Zooming With LD, a Leading Platform for Microcap Companies

CEO Tim Moore will appear on Tuesday, March 24th at 8:00 AM PT/ 11:00 AM ET Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, announced today that it will …

Havn Life CEO to Present at Zooming With LD, a Leading Platform for Microcap Companies Read More »

Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer

Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer

Pozar will lead sales, marketing, e-commerce and logistics for Havn Retail Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FRA: 5NP) (FSE: 5NP)  (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce that industry veteran Jenna Pozar …

Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer Read More »

Scroll to Top